Gland Pharma Ltd.'s market cap is currently ₹256.53B. The company's EPS TTM is ₹41.983; its P/E ratio is 37.09; and it has a dividend yield of 1.28%. Gland Pharma Ltd. is scheduled to report earnings on February 3, 2025, and the estimated EPS forecast is ₹12.46. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	₹ 56.42B	₹ 36.25B	₹ 43.84B	₹ 34.24B	₹ 25.72B
Gross Profit	₹ 30.88B	₹ 19.39B	₹ 22.75B	₹ 19.32B	₹ 14.70B
Operating Income	₹ 16.45B	₹ 8.84B	₹ 14.00B	₹ 12.03B	₹ 8.61B
EBITDA	₹ 15.03B	₹ 12.09B	₹ 17.34B	₹ 14.37B	₹ 10.95B
Net Income	₹ 7.72B	₹ 7.81B	₹ 12.12B	₹ 9.97B	₹ 7.73B
Balance Sheet
Cash & Short-Term Investments	₹ 19.39B	₹ 38.36B	₹ 32.43B	₹ 24.47B	₹ 13.12B
Total Assets	₹ 106.61B	₹ 87.78B	₹ 78.34B	₹ 64.96B	₹ 40.86B
Total Debt	₹ 3.72B	₹ 44.53M	₹ 47.43M	₹ 49.95M	₹ 60.11M
Net Debt	₹ 150.78M	₹ -19.04B	₹ -3.11B	₹ -4.87B	₹ -1.63B
Total Liabilities	₹ 19.37B	₹ 8.19B	₹ 6.76B	₹ 5.93B	₹ 4.40B
Stockholders' Equity	₹ 87.24B	₹ 79.59B	₹ 71.58B	₹ 59.03B	₹ 36.46B
Cash Flow
Free Cash Flow	₹ 5.99B	₹ 1.41B	₹ 2.69B	₹ 3.76B	₹ 5.06B
Operating Cash Flow	₹ 9.97B	₹ 3.64B	₹ 7.91B	₹ 6.05B	₹ 7.01B
Investing Cash Flow	₹ -17.57B	₹ 12.08B	₹ -10.03B	₹ -15.24B	₹ -7.66B
Financing Cash Flow	₹ -7.99B	₹ 149.19M	₹ 348.98M	₹ 12.38B	₹ -68.71M

Currency in INR

Gland Pharma Ltd. Earnings and Revenue History

Income Statement >

Gland Pharma Ltd. Debt to Assets

Balance Sheet >

Gland Pharma Ltd. Cash Flow

Cash Flow >

Gland Pharma Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing